https://stock.noler.com/us/stock/bellerophon-therapeutics-inc https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/accounts-payable-trade-current https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/accounts-payable-underwriters-promoters-and-employees-other-than-salaries-and-wages-current https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/accretion-amortization-of-discounts-and-premiums-investments https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/accrued-income-taxes https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/accrued-liabilities-current https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/accumulated-depreciation https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/additional-paid-in-capital https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/adjustments-related-to-tax-withholding-for-share-based-compensation https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/allocated-share-based-compensation-expense-net-of-tax https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/amortization-of-financing-costs https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/aoci https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/assets-net https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/available-for-sale-accumulated-gross-unrealized-gain-before-tax https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/available-for-sale-accumulated-gross-unrealized-loss-before-tax https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/available-for-sale-amortized-cost https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/available-for-sale-change-in-net-unrealized-holding-gain-loss-net-of-tax https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/available-for-sale-debt-accumulated-gross-unrealized-gain-before-tax https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/available-for-sale-debt-accumulated-gross-unrealized-loss-before-tax https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/available-for-sale-debt-amortized-cost-basis https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/available-for-sale-debt-maturities-after-one-through-five-years-fair-value https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/available-for-sale-debt-maturities-within-one-year-amortized-cost https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/available-for-sale-debt-maturities-within-one-year-fair-value https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/available-for-sale-debt-securities https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/available-for-sale-securities https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/basic-shares https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/capital-expenditures https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/cash https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/cash-and-cash-equivalents-change https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/cash-and-equivalents https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/cash-and-restricted-cash https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/cash-and-restricted-cash-including-disposal-group-and-discontinued-operations https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/cash-flow-breakdown https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/class-of-warrant-or-right-exercise-price-of-warrants-or-rights https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/class-of-warrant-or-right-outstanding https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/common-stock-value https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/comprehensive-income https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/contribution-of-property https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/cost-of-goods-and-services-sold-depreciation https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/current-assets https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/current-liabilities https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/debt-fee-amount https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/debt-issuance-costs https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/debt-related-commitment-fees-and-debt-issuance-costs https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/deferred-finance-costs-noncurrent-net https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/deferred-income-tax-liabilities https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/deferred-tax-assets-goodwill-and-intangible-assets https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/deferred-tax-assets-gross https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/deferred-tax-assets-liabilities-net https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/deferred-tax-assets-net https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/deferred-tax-assets-property-plant-and-equipment https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/deferred-tax-assets-stock-compensation https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/deferred-tax-assets-tax-credit-carryforwards-research https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/deferred-tax-liabilities-property-plant-and-equipment https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/depreciation-nonproduction https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/derivative-liabilities-current https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/diluted-shares https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/dilutive-shares https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/due-from-affiliate-current https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/due-from-related-parties-current https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/due-to-affiliate-current https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/due-to-related-parties-current https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/effective-tax-rate https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/eps https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/eps-basic https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/fair-value-adjustment-of-warrants https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/financing-cash-flow https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/form-d-other https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/gain-loss-on-sale-of-property-plant-equipment https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/general-and-administrative-expense https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/income-tax https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/increase-decrease-in-accounts-payable-and-accrued-liabilities https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/increase-decrease-in-due-from-affiliates-current https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/increase-decrease-in-due-from-related-parties-current https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/increase-decrease-in-due-to-affiliates https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/increase-decrease-in-due-to-related-parties-current https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/increase-decrease-in-other-noncurrent-assets https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/increase-decrease-in-restricted-cash-for-operating-activities https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/incremental-common-shares-attributable-to-share-based-payment-arrangements https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/insider-transactions-stock-options https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/insider-transactions-stock-units https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/insider-transactions-warrants https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/insider-transactions-warrants/purchases https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/interest-income-operating https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/investing-cash-flow https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/investment-income-interest https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/investments-fair-value-disclosure https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/lease-and-rental-expense https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/lessee-operating-lease-liability-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/lessee-operating-lease-liability-undiscounted-excess-amount https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/liabilities-fair-value-disclosure https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/line-of-credit-facility-capacity-available-for-specific-purpose-other-than-for-trade-purchases https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/line-of-credit-facility-interest-rate https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/line-of-credit-facility-maximum-borrowing-capacity https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/marketable-securities https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/members-capital https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/net-cash-from-financing-activities https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/net-cash-from-investing-activities https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/net-cash-from-operating-activities https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/net-change-in-cash https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/net-income https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/net-income-loss-available-to-common-stockholders-basic https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/number-of-reportable-segments https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/oci-available-for-sale-adjustment-net-of-tax https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/oci-net-of-tax https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/oci-net-of-tax-2 https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/operating-cash-flow https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/operating-expenses https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/operating-income https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/operating-lease-assets https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/operating-lease-cost https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/operating-lease-expense https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/operating-lease-liability https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/operating-lease-liability-current https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/operating-lease-liability-noncurrent https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/operating-lease-payments https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/operating-lease-payments-due https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/operating-lease-payments-due-2 https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/operating-lease-payments-due-current https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/operating-lease-payments-due-in-five-years https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/operating-lease-payments-due-in-four-years https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/operating-lease-payments-due-in-three-years https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/operating-lease-payments-due-in-two-years https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/operating-lease-payments-due-next-twelve-months https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/operating-lease-payments-due-thereafter https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/operating-lease-payments-due-year-five https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/operating-lease-payments-due-year-four https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/operating-lease-payments-due-year-three https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/operating-lease-payments-due-year-two https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/operating-lease-weighted-average-discount-rate-percent https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/other-accrued-liabilities-current https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/other-income https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/other-noncash-expense https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/other-noncash-income-expense https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/other-noncurrent-assets https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/other-operating-income https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/paid-in-capital-warrant-issued https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/payments-for-deposits https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/payments-for-restructuring https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/payments-of-stock-issuance-costs https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/payments-to-acquire-marketable-securities https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/payments-to-acquire-short-term-investments https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/preferred-shares-facts https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/preferred-stock-shares-authorized https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/preferred-stock-shares-issued https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/preferred-stock-value https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/pretax-income https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/proceeds-from-issuance-of-private-placement https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/proceeds-from-issuance-or-sale-of-equity https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/proceeds-from-sale-and-maturity-of-marketable-securities https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/proceeds-from-sale-of-interest-in-corporate-unit https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/proceeds-from-sale-of-property-plant-and-equipment https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/proceeds-from-stock-issued https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/proceeds-from-stock-options-exercised https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/proceeds-from-warrant-exercises https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/profit-loss https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/property-plant-and-equipment-gross https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/property-plant-equipment https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/public-float https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/research-and-development-expense-excluding-acquired-in-process-cost https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/restricted-cash-and-cash-equivalents-at-carrying-value https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/restricted-cash-and-cash-equivalents-noncurrent https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/restructuring-charges https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/restructuring-reserve https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/restructuring-reserve-accrual-adjustment https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/retained-earnings https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/revenue-from-contract-with-customer-including-assessed-tax https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/right-of-use-asset-obtained-in-exchange-for-operating-lease-liability https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/shareholders-equity https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/shares-authorized https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/shares-issued https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/shares-issued-price-per-share https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/shares-repurchased-value https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/short-term-investments https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/significant-change-in-utb-is-reasonably-possible-amount-of-unrecorded-benefit https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/stock-award-non-option-equity-instruments-granted https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/stock-award-non-option-equity-instruments-outstanding-number https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/stock-award-number-of-shares-available-for-grant https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/stock-award-rsu-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/stock-based-compensation https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/stock-compensation-tax-benefit-from-compensation-expense https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/stock-issued-shares-issued-shares-new-issues https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/stock-issued-shares-issued-value-issued-for-services https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/stock-issued-shares-issued-value-restricted-stock-award-net-of-forfeitures https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/stock-options-exercisable-intrinsic-value https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/stock-options-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/stock-options-outstanding-intrinsic-value https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/stock-options-vested-and-expected-to-vest-exercisable-aggregate-intrinsic-value https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/stock-split-ratio https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/stockholders-equity-note-spinoff-transaction https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/tax-rate-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/tax-rate-reconciliation-change-in-enacted-tax-rate https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/tax-rate-reconciliation-nondeductible-expense-share-based-compensation-cost https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/tax-rate-reconciliation-other-adjustments https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/tax-rate-reconciliation-prior-year-income-taxes https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/tax-rate-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/tax-rate-reconciliation-tax-credits-research https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/tax-withholding-on-stock-awards https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/total-assets https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/total-liabilities https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/unrecognized-tax-benefits https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/warrants-and-rights-outstanding https://stock.noler.com/us/stock/bellerophon-therapeutics-inc/weighted-average-number-of-share-outstanding-basic-and-diluted